NITROFURANTOIN BNM (Boucher & Muir Pty Ltd)
Product name
NITROFURANTOIN BNM
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
132 (255 working days)
Active ingredients
nitrofurantoin
Registration type
New generic medicine
Indication
NITROFURANTOIN BNM (hard capsule) is indicated for the treatment of urinary tract infections such as cystitis and pyelitis when due to susceptible pathogens. Nitrofurantoin does not reach effective levels in plasma and consequently is not indicated for cortical or perinephric abscesses and in cases of prostatitis.